Immunomodulatory Therapeutic Strategies in Stroke
The role of immunity in all stages of stroke is increasingly being recognized, from the pathogenesis of risk factors to tissue repair, leading to the investigation of a range of immunomodulatory therapies. In the acute phase of stroke, proposed therapies include drugs targeting pro-inflammatory cyto...
Saved in:
Main Authors: | Kyle Malone (Author), Sylvie Amu (Author), Anne C. Moore (Author), Christian Waeber (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities
by: Andrea C. Diaz Diaz, et al.
Published: (2022) -
Acute Treatment With Fingolimod Does Not Confer Long-Term Benefit in a Mouse Model of Intracerebral Haemorrhage
by: Andrea C. Diaz Diaz, et al.
Published: (2021) -
Innovative Therapeutic and Immunomodulatory Strategies for Protozoan Infections
Published: (2019) -
Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics
by: Sandeep Paudel, et al.
Published: (2023) -
Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory Disorders
by: Sherri L. Christian, et al.
Published: (2018)